您的购物车当前为空
别名 芦舍司他, OGT 923, NBDGJ, NB DGJ, N-(n-Butyl)deoxygalactonojirimycin, ACT 434964
Lucerastat(NBDGJ,芦舍司他)是一种口服的葡萄糖神经酰胺合酶(Glucosylceramide Synthase, GCS)的抑制剂,具有治疗法布里病的潜力。 GCS是鞘糖脂合成的关键酶,抑制其活性可减少有害底物的积累。

Lucerastat(NBDGJ,芦舍司他)是一种口服的葡萄糖神经酰胺合酶(Glucosylceramide Synthase, GCS)的抑制剂,具有治疗法布里病的潜力。 GCS是鞘糖脂合成的关键酶,抑制其活性可减少有害底物的积累。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 4,399 | In stock |
Lucerastat 相关产品
| 产品描述 | Lucerastat(NBDGJ) is an orally available inhibitor of Glucosylceramide Synthase (GCS) with therapeutic potential for Fabry disease. GCS is a key enzyme in sphingolipid synthesis and inhibition of its activity reduces the accumulation of harmful substrates. |
| 别名 | 芦舍司他, OGT 923, NBDGJ, NB DGJ, N-(n-Butyl)deoxygalactonojirimycin, ACT 434964 |
| 分子量 | 219.28 |
| 分子式 | C10H21NO4 |
| CAS No. | 141206-42-0 |
| Smiles | C(CCC)N1[C@H](CO)[C@H](O)[C@H](O)[C@@H](O)C1 |
| 密度 | 1.234 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 20 mg/mL (91.21 mM), Sonication is recommended. H2O: 20 mg/mL (91.21 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO/H2O
| |||||||||||||||||||||||||||||||
评论内容